Onoue S, Yamada S, Yajima T
Retatrutide adds a third target the glucagon receptor (GCGR) which is hypothesised to further increase energy expenditure and hepatic fat oxidation, though this remains investigational and unconfirmed in phase 3 trials
1995 Oct;80(10):2987-92
This is a condition where the salivary glands do not produce enough saliva to keep the mouth wet
PlexusDx screens for these conditions during consultation and ensures compounded semaglutide is sourced from licensed 503A pharmacies meeting pharmaceutical-grade standards
Ingredients: water, L-carnitine, pantothenic acid (D-pantothenate, calcium), acids (E330, E296), flavouring, sweeteners (acesulfame K, sucralose, neotame, steviol glycosides from Stevia), preservatives (potassium sorbate, sodium benzoate), colour (E133), maltodextrin